Comparison of the prognostic values of selected inflammation based scores in patients with medullary thyroid carcinoma: A pilot study

The significance of inflammation based scores including the neutrophil‐to‐lymphocyte ratio (NLR), derived neutrophil‐to‐lymphocyte ratio (dNLR), platelet‐to‐lymphocyte ratio (PLR), lymphocyte‐to‐monocyte ratio (LMR), prognostic nutritional index (PNI), and plasma fibrinogen remains unclear in medullary thyroid carcinoma (MTC). We aimed to compare the prognostic value of these scores.

[1]  L. Coussens,et al.  Inflammation and Cancer , 2016 .

[2]  Zhihui Li,et al.  Association of the preoperative neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios with lymph node metastasis and recurrence in patients with medullary thyroid carcinoma , 2016, Medicine.

[3]  P. Gao,et al.  The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: A meta-analysis. , 2016, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

[4]  T. Mohri,et al.  Impact of prognostic nutritional index on long-term outcomes in patients with breast cancer , 2016, World Journal of Surgical Oncology.

[5]  C. Kwak,et al.  Preoperative Plasma Fibrinogen Level as a Significant Prognostic Factor in Patients With Localized Renal Cell Carcinoma After Surgical Treatment , 2016, Medicine.

[6]  Yang Li,et al.  Lymphocyte-to-monocyte ratio predicts survival of patients with hepatocellular carcinoma after curative resection. , 2015, World journal of gastroenterology.

[7]  T. Yeh,et al.  Prognostic Value of the Preoperative Neutrophil to Lymphocyte Ratio in Resectable Gastric Cancer , 2015, Medicine.

[8]  Douglas B. Evans,et al.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma. , 2015, Thyroid : official journal of the American Thyroid Association.

[9]  R. Sun,et al.  The elevated pretreatment platelet-to-lymphocyte ratio predicts poor outcome in nasopharyngeal carcinoma patients , 2015, Tumor Biology.

[10]  J. Vauthey,et al.  Cytokine profile and prognostic significance of high neutrophil-lymphocyte ratio in colorectal cancer , 2015, British Journal of Cancer.

[11]  A. Falanga,et al.  The coagulopathy of cancer , 2014, Current opinion in hematology.

[12]  K. Lorenz,et al.  Utility of serum procalcitonin for screening and risk stratification of medullary thyroid cancer. , 2014, The Journal of clinical endocrinology and metabolism.

[13]  L. Duntas,et al.  Fine needle aspiration and medullary thyroid carcinoma: the risk of inadequate preoperative evaluation and initial surgery when relying upon FNAB cytology alone. , 2013, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.

[14]  H. Tajiri,et al.  Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma , 2012, British Journal of Cancer.

[15]  T. Nozoe,et al.  The prognostic nutritional index can be a prognostic indicator in colorectal carcinoma , 2012, Surgery Today.

[16]  Fenghua Wang,et al.  Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer , 2012, Medical Oncology.

[17]  B. North,et al.  A novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI) , 2012, British Journal of Cancer.

[18]  D. Talwar,et al.  A comparison of inflammation-based prognostic scores in patients with cancer. A Glasgow Inflammation Outcome Study. , 2011, European journal of cancer.

[19]  L. Orloff,et al.  Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer , 2011, The Laryngoscope.

[20]  N. Morgenthaler,et al.  Basal and stimulated calcitonin and procalcitonin by various assays in patients with and without medullary thyroid cancer. , 2011, Clinical chemistry.

[21]  M. Karin,et al.  Immunity, Inflammation, and Cancer , 2010, Cell.

[22]  L. Hefler,et al.  The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial , 2010, British Journal of Cancer.

[23]  A. Algeciras-Schimnich,et al.  Procalcitonin: a marker for the diagnosis and follow-up of patients with medullary thyroid carcinoma. , 2009, The Journal of clinical endocrinology and metabolism.

[24]  J. Palumbo.  Mechanisms linking tumor cell-associated procoagulant function to tumor dissemination. , 2008, Seminars in thrombosis and hemostasis.

[25]  S. Roman,et al.  Prognosis of medullary thyroid carcinoma , 2006, Cancer.

[26]  M. Mosesson.  Fibrinogen and fibrin structure and functions , 2005, Journal of thrombosis and haemostasis : JTH.

[27]  E. Baudin,et al.  Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer. , 2003, The Journal of clinical endocrinology and metabolism.

[28]  B. Rybarczyk,et al.  Tumors and Fibrinogen , 2001, Annals of the New York Academy of Sciences.

[29]  Alberto Mantovani,et al.  Inflammation and cancer: back to Virchow? , 2001, The Lancet.

[30]  Q. Duh,et al.  Medullary thyroid carcinoma , 2000, Cancer.

[31]  J. Moley,et al.  Patterns of nodal metastases in palpable medullary thyroid carcinoma: recommendations for extent of node dissection. , 1999, Annals of surgery.

[32]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients , 1998 .

[33]  T. Ulich,et al.  Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-alpha-induced changes in circulating numbers of neutrophils and lymphocytes. , 1987, Journal of immunology.

[34]  G. Kōsaki,et al.  [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. , 1984, Nihon Geka Gakkai zasshi.

[35]  U. Langsenlehner,et al.  The elevated preoperative derived neutrophil-to-lymphocyte ratio predicts poor clinical outcome in breast cancer patients , 2015, Tumor Biology.

[36]  M. Schlumberger,et al.  Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'étude des tumeurs à calcitonine. , 1998, Clinical endocrinology.

[37]  T. Ulich,et al.  In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs. , 1989, Blood.